Urorectal septum
Structure in embryonic development
The urorectal septum is a crucial structure in the development of the embryo, specifically in the formation of the urogenital system and the gastrointestinal tract. It plays a significant role in separating the cloaca into the urogenital sinus and the anorectal canal.
Development[edit | edit source]
The development of the urorectal septum occurs during the early stages of embryogenesis. It begins as a mesodermal wedge that grows caudally between the allantois and the hindgut. This process is essential for the proper partitioning of the cloaca, a common cavity that initially serves as the terminal end of the digestive and urogenital tracts.
As the embryo develops, the urorectal septum extends towards the cloacal membrane. By the end of the seventh week of gestation, the septum reaches the cloacal membrane, dividing it into the urogenital membrane and the anal membrane. This division is critical for the formation of separate openings for the urinary and digestive systems.
Function[edit | edit source]
The primary function of the urorectal septum is to separate the cloaca into two distinct regions:
- The urogenital sinus, which will give rise to structures such as the bladder, urethra, and in males, parts of the reproductive system.
- The anorectal canal, which will develop into the rectum and anal canal.
This separation is vital for the proper functioning of the urinary and digestive systems after birth.
Clinical Significance[edit | edit source]
Abnormal development of the urorectal septum can lead to congenital anomalies such as cloacal malformations or anorectal malformations. These conditions can result in a range of complications, including improper separation of the urinary and digestive tracts, leading to issues such as fistulas or atresia.
Surgical intervention is often required to correct these anomalies and ensure normal function of the affected systems.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD